Philipp Dahm, MD

Professor, Department of Urology

Philipp Dahm

Contact Info

Administrative Assistant Name
Liz Mayock

Administrative Phone

Administrative Fax Number

Additional Locations


University of Essen, School of Medicine, Germany (10/1986-9/1988) University of Graz, School of Medicine, Austria (10/1988-9/1989) University of Heidelberg, School of Medicine, Germany (10/1989-4/1994)

University of Tübingen, Department of Surgery, Tübingen, Germany, 1/1995 – 5/1996

Duke University Medical Center, Department of Surgery, Durham, NC 6/1996-6/1998 – Intern and Junior Assistant Resident

Duke University Medical Center, Division of Urology 6/1998-6/2001 – Senior Assistant Resident

6/2001-6/2002 – Chief Resident


Dr. Philipp Dahm, MD, MHSc, FACS is Professor of Urology and Vice Chair of Veterans Affairs at the University of Minnesota. He also serves as Director of Research and Education for Surgical Services at the Minneapolis Veterans Administration Medical Center.

A board certified urologist, Dr. Dahm graduated from the University of Heidelberg in Germany before starting residency in general surgery and urology at Duke University in Durham, North Carolina. He subsequently completed an American Foundation for Urological Diseases (AFUD) fellowship at the same institution and earned a Masters degree in Health Sciences in Clinical Research from the Duke Clinical Research Institute. He was an Assistant Professor of Urology at Duke University Medical Center until 2006 when he moved to the University of Florida in Gainesville, where he held the rank of Associate Professor (2006-11) and Professor of Urology (2011-14). During the time, he also held the departmental positions of Director of Clinical Research (2006-14), Associate Residency Program Director (2006-2010) and Residency Program Director (2011-14).

Dr. Dahm is a fellow of the American College of Surgeons and an active member of the American Urologic Association. He has published more than 120 peer-reviewed articles and several book chapters. He is best known for his efforts to promote the principles of evidence-based medicine in urology through research and education. Dr. Dahm serves as the Coordinating Editor of the Cochrane Prostatic Diseases and Urological Cancers Group. He is also the urology lead of the IDEAL Collaboration that strives to improve how surgeons conduct clinical research as well as founding member of the US GRADE Network that promotes transparent methods for guideline development and clinical decision-making.

Professional Associations

Vice Chair of Veterans Affairs



1. Langendam, M.W., Akl, E.A., Dahm, P., Glasziou, P., Guyatt, G., Schünemann, H.J.: Assessing and presenting summaries of evidence in Cochrane Reviews. Syst Rev (2013) 2(1):81. doi:10.1186/2046-4053-2-81.

2. McCulloch, P., Cook, J.A., Altman, D.G., Heneghan, C., Diener, M.K., on behalf of the IDEAL group: IDEAL framework for surgical innovation 1: the idea and development stages. BMJ (2013) 346:f3012. doi:10.1136/bmj.f3012.

3. Ergina, P.L., Barkun, J.S., McCulloch, P., Cook, J.A., Altman, D.G., on behalf of the IDEAL group: IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages. BMJ (2013) 346:f3011. doi:10.1136/bmj.f3011.

4. Cook, J.A., McCulloch, P., Blazeby, J.M., Beard, D.J., Marinac-Dabic, D., Sedrakyan, A., on behalf of the IDEAL group: IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ (2013) 346:f2820. doi:10.1136/bmj.f2820.

5. Kluth, L.A., Rink, M., Ahyai, S.A., Fisch, M., Shariat, S.F., Dahm, P.: Vorzeitiger Abbruch randomisierter kontrollierter Studien: vorteilsbedingter therapieeffekt [Randomized controlled trials terminated prematurely: beneficial therapy effects]. Urologe A (2013) 52(8):1080-3. doi:10.1007/s00120-013-3144-2.

6. Donat, S.M., Diaz, M., Bishoff, J.T., Coleman, J.A., Dahm, P., Derweesh, I.H., Herrell, III
S.D. 3rd, Hilton, S., Jonasch, E., Lin, D.W., Reuter, V.E., Chang, S.S.: Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol (2013) 190(2):407-16. doi:10.1016/j.juro.2013.04.121.

7. Cookson, M.S., Roth, B.J., Dahm, P., Engstrom, C., Freedland, S.J., Hussain, M., Lin, D.W., Lowrance, W.T., Murad, M.H., Oh, W.K., Penson, D.F., Kibel, A.S.: Castration-resistant prostate cancer: AUA guideline. J Urol (2013) 190(2):429-38. doi:10.1016/j.juro.2013.05.005.

8. Kluth, L.A., Rink, M., Chun, F.K.H., Fisch, M., Shariat, S.F., Dahm, P.: Die „likelihood ratio“: beeinflussung der therapieentscheidung durch einen diagnostischen test [The likelihood ratio: estimation of the impact of a diagnostic test on treatment decision]. Urologe A (2013) 52(7):982-5. doi:10.1007/s00120-013-3145-1.

9. Zavitsanos, P., Bird, V.G., Mince, K., Neuberger, M.M., Dahm, P.: Low methodological and reporting quality of randomized controlled trials for devices to treat urolithiasis [AUA 2013 Abstract]. J Urol (2013) 189(4 Suppl):e812-3.

10. Pugh, J., Flowers, K., Neuberger, M.M., Odedina, F., Vieweg, J., Gilbert, S.M., Dahm, P.: Enrollment of black men in prostate cancer randomized controlled trials [AUA 2013 Abstract]. J Urol (2013) 189(4 Suppl):e24-5.

11. Rink, M., Kluth, L.A., Shariat, S.F., Fisch, M., Dahlem, R., Dahm, P.: Kaplan-Meier-analysen in der urologischen praxis [Kaplan-Meier analysis in urological practice]. Urologe A (2013) 52(6):838-41. doi:10.1007/s00120-013-3150-4.

12. Kluth, L.A., Rink, M., Shariat, S.F., Chun, F.K., Fisch, M., Dahm, P.: Verwendung und Bedeutung der „number needed to treat” in der urologischen Praxis [Use and interpretation of the number needed to treat in urological practice]. Urologe A (2013) 52(5):682-5. doi:10.1007/s00120-013-3149-x.

13. Andrews, J., Guyatt, G., Oxman, A.D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P.N., Kunz, R., Brozek, J., Vist, G., Rind, D., Akl, E.A., Schünemann, H.J.: GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 66(7):719-25. doi:10.1016/j.jclinepi.2012.03.013

14. Rink, M., Kluth, L.A., Shariat, S.F., Dahlem, R., Fisch, M., Dahm, P.: Konfidenzintervalle und p-Werte in der Urologie: Interpretation und Fehlinterpretation [Confidence intervals and p-values in urology: interpretation and misinterpretation]. Urologe A (2013) 52(4):546-8. doi:10.1007/s00120-013-3148-y.

15. Yi, Y., Breau, R.H., Witiuk, K., Neuberger, M.M., Dahm, P.: Diagnostic tests in urology: percentage of free prostate-specific antigen (PSA). BJU Int (2013) 111(4):683-5. doi: 10.1111/j.1464-410X.2012.11446.x.

16. Rink, M., Kluth, L.A., Shariat, S.F., Chun, F.K., Fisch, M., Dahm, P.: Die Verwendung von PubMed zur Verbesserung evidenzbasierter Medizin in der Urologie [Use of PubMed to improve evidence-based medicine in routine urological practice]. Urologe A (2013) 52(3):367-72. doi:10.1007/s00120-013-3147-z.

17. Bell, M.D., Lavallée, L.T., Dahm, P., Witiuk, K., Breau, R.H.: Diagnostic Tests in Urology: Percutaneous Biopsy of Renal Masses. BJU Int (2013) 111(2):362-4. doi: 10.1111/j.1464- 410X.2012.11440.x.

18. Bala, M.M., Akl, E.A., Sun, X., Bassler, D., Mertz, D., Mejza, F., Vandvik, P.O., Malaga, G., Johnston, B.C., Dahm, P., Alonso-Coello, P., Diaz-Granados, N., Srinathan, S.K., Hassouneh, B., Briel, M., Busse, J.W., You, J.J., Walter, S.D., Altman, D.G., Guyatt, G.H.: Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysis. J Clin Epidemiol (2013) 66(3):286-95.

19. Guyatt, G., Oxman, A.D., Sultan, S., Brozek, J., Glasziou, P., Alonso-Coello, P., Atkins, D., Kunz, R., Montori, V., Jaeschke, R., Rind, D., Dahm, P., Akl, E.A., Meerpohl, J., Vist, G., Berliner, E., Norris, S., Falck-Ytter, Y., Schünemann, H.J.: GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol (2013) 66(2):151-7. doi: 10.1016/j.jclinepi.2012.01.006.

20. Lavallée, L.T., Fergusson, D., Dahm, P., Scales Jr., C.D., Witiuk, K., Breau, R.H.: Diagnostic tests in urology: urine cytology. BJU Int (2012) 110(11c):E789-91. doi: 10.1111/j.1464- 410X.2012.11448.x.

21. Chang, S.S., Dinney, C.P.N., Donat, S.M., Dahm, P., Gore, J.L., Lotan, Y., Parekh, D.J., Solit, D.B., O'Donnell, P.H., Feng, F.Y., Hansel, D., Milowsky, M.I.: 12th Annual Meeting of the Society of Urologic Oncology (SUO) Bladder Cancer Sessions I and II summary report. Urol Oncol (2012) 30(6):944-7. doi: 10.1016/j.urolonc.2012.07.006.

22. MacLennan, S., Imamura, M., Lapitan, M.C., Omar, M.I., Lam, T.B.L., Hilvano-Cabungcal, A.M., Royle, P., Stewart, F., MacLennan, G., MacLennan, S.J., Dahm, P., Canfield, S.E., McClinton, S., Griffiths, T.R.L., Ljungberg, B., N’Dow, J., UCAN Systematic Review Reference Group and the EAU Renal Cancer Guideline Panel: Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol (2012) 62(6):1097-117.

23. Kerwin, A.J., Haut, E.R., Burns, B., Como, J.J., Haider, A., Stassen, N., Dahm, P.; and Eastern Association for the Surgery of Trauma Practice Management Guidelines Ad Hoc Committee: The Eastern Association of the Surgery of Trauma approach to practice management guideline development using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. J Trauma Acute Care Surg (2012) 73(5 Suppl 4):S283-7. doi: 10.1097/TA.0b013e31827013e9.

24. Akhavein, A., Neuberger, M.M., Dahm, P.: Tumour-seeding: a rare complication of ablative therapy for clinically localised renal cell carcinoma. BMJ Case Rep (2012). doi: 10.1136/bcr- 2012-006948.

25. D’Silva, K.A., Dahm, P., Wong, C.L.: Does this patient with LUTS have benign prostatic hypertrophy with bladder outlet obstruction? Can Geriatr J (2012) 15(2):61.

26. Sun, X., Briel, M., Busse, J.W., You, J.J., Akl, E.A., Mejza, F., Bala, M.M., Bassler, D., Mertz, D., Diaz-Granados, N., Vandvik, P.O., Malaga, G., Srinathan, S.K., Dahm, P., Johnston, B.C., Alonso-Coello, P., Hassouneh, B., Walter, S.D., Heels-Ansdell, D., Bhatnagar, N., Altman, D.G., Guyatt, G.H.: Credibility of claims of subgroup effects in randomised controlled trials: Systematic review. BMJ (2012) 344:e1553. doi: 10.1136/bmj.e1553

27. Eruslanov, E., Neuberger, M., Daurkin, I., Perrin, G.Q., Algood, C., Dahm, P., Rosser, C., Vieweg, J., Gilbert, S.M., Kusmartsev, S.: Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer (2012) 130(5):1109-19. doi: 10.1002/ijc.26123

28. Kang, D.C., Palmer, D.A., Zarei, M., Shah, P., Folsom, C., Beyth, R.J., Stoffs, T.L., Neuberger, M.M., Dahm, P.: A Systematic Review of the Quality of Evidence of Ablative Therapy for Small Renal Masses. J Urol (2012) 187(1):44-7. doi:10.1016/j.juro.2011.09.046

29. Imamura, M., MacLennan, S., Lapitan, M.C., Omar, I.M., Lam, T.B.L., Hilvano-Cabungcal, A.M., Royle, P., Stewart, F., MacLennan, G., MacLennan, S.J., Canfield, S.J., Dahm, P., Aitchison, M., McClinton, S., Griffiths, T.R.L., Ljungberg, B., N’Dow, J., the UCAN Systematic Review Reference Group and the EAU Guideline Group for renal cell carcinoma: Systematic review of the clinical effectiveness of surgical management for localised renal cell carcinoma. Aberdeen, UK: University of Aberdeen, Academic Urology Unit; 2011 Oct.

30. Sur, R.L., Dahm, P.: History of evidence-based medicine. Indian J Urol (2011) 27(4):487-9. doi:10.4103/0970-1591.91438

31. Clubb, A.B., Dahm, P.: How to critically appraise a clinical practice guideline. Indian J Urol (2011) 27(4):498-502. doi:10.4103/0970-1591.91441

32. Stewart, S.B., Dahm, P., Scales, C.D.: How to appraise the effectiveness of treatment. Indian J Urol (2011) 27(4):525-31. doi:10.4103/0970-1591.91446

33. Reyner, K., Dahm, P.: Leukocytoclastic vasculitis presenting with acute haemorrhagic oedema of the scrotum. BMJ Case Rep (2011) doi:10.1136/bcr.08.2011.4666.

34. Guyatt, G.H., Oxman, A.D., Sultan, S., Glasziou, P., Akl, E.A., Alonso-Coello, P., Atkins, D., Kunz, R., Brozek, J., Montori, V., Jaeschke, R., Rind, D., Dahm, P., Meerpohl, J., Vist, G., Berliner, E., Norris, S., Falck-Ytter, Y., Murad, M.H., Schünemann, H.J.; The GRADE Working Group: GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol (2011) 64(12):1311-6. doi:10.1016/j.jclinepi.2011.06.004

35. Guyatt, G.H., Oxman, A.D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., Alonso-Coello, P., Glasziou, P., Jaeschke, R., Akl, E.A., Norris, S., Vist, G., Dahm, P., Shukla, V.K., Higgins, J., Falck-Ytter, Y., Schünemann, H.J.; The GRADE Working Group: GRADE guidelines: 7. Rating the quality of evidence—inconsistency. J Clin Epidemiol (2011) 64(12):1294-1302. doi: 10.1016/j.jclinepi.2011.03.017

36. Vogel, B., Gilbert, S.M., Boylston Herndon, J., Dahm, P.: Advanced topics in evidence-based urologic oncology: Economic analysis. Urol Oncol. (2011) 29(4):454-61. doi:10.1016/j.urolonc.2010.07.018

37. Dahm, P., Kang, D., Stoffs, T.L., Canfield, S.E.: Recovery of Erectile Function After Robotic Prostatectomy: Evidence-Based Outcomes. Urol Clin North Am (2011) 38(2):95-103. doi: 10.1016/j.ucl.2011.02.001

38. Canfield, S.E., Dahm, P.: Rating the quality of evidence and the strength of recommendations using GRADE. World J Urol (2011) 29(3):311-7. doi: 10.1007/s00345-011-0667-2

39. Maclennan, S.J., Maclennan, S.J., Imamura, M., Omar, M.I., Vale, L., Lam, T., Royle, P., Royle, J., Swami, S., Pickard, R., McClinton, S., Griffiths, T.R., Dahm, P., N'dow, J.; and the UCAN Care Pathway Development Group: Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines. World J Urol (2011) 29(3):291-301. doi: 10.1007/s00345-011-0660-9

40. Willis, D.L., Bahler, C.D., Neuberger, M.M., Dahm, P.: Predictors of citations in the urological literature. BJU Int (2011) 107(12):1876-80.

41. Sun, X., Briel, M., Busse, J.W., You, J.J., Akl, E.A., Mejza, F., Bala, M.M., Bassler, D., Mertz, D., Diaz-Granados, N., Vandvik, P.O., Malaga, G., Srinathan, S.K., Dahm, P., Johnston, B.C., Alonso-Coello, P., Hassouneh, B., Truong, J., Dattani, N.D., Walter, S.D., Heels-Ansdell, D., Bhatnagar, N., Altman, D.G., Guyatt, G.H.: The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review. BMJ (2011) 342:d1569.

42. Guyatt, G., Oxman, A.D., Akl, E., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., Debeer, H., Jaeschke, R., Rind, D., Meerpohl, J., Dahm, P., Schünemann, H.J.: GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2011) 64(4):383-94.

43. Canfield, S.E., Sultan, S., Dahm, P.; Evidence-Based Urology Working Group.: Evidence- based urology in practice: randomized controlled trials stopped early for benefit. BJU Int (2010) 106(7):962-3.

44. Djulbegovic, M., Beyth, R.J., Neuberger, M.M., Stoffs, T.L., Vieweg, J., Djulbegovic, B., Dahm, P.: Screening for Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. BMJ (2010) 341:c4543.

45. Macdonald, S.L., Scales Jr., C.D., Dahm, P.; the Evidence-Based Urology (EBU) Working Group. Evidence-based urology in practice: P-values vs confidence intervals. BJU Int (2010) 106(6):758-9.

46. MacDonald, S.L., Canfield, S.E., Fesperman, S.F, Dahm, P.: Assessment of the methodological quality of systematic reviews published in the urological literature from 1998 to 2008. J Urol. (2010) 184(2):648-53.

47. Breau, R.H., Gaboury, I., Scales Jr., C.D., Fesperman, S.F., Watterson, J.D., Dahm, P.: Reporting of harm in randomized controlled trials published in the urological literature. J Urol. (2010) 183(5):1693-7.

48. Lavallée, L.T., Dahm, P., Breau, R.H.: Evidence-based urology in practice: composite endpoints. BJU Int (2010) 106(5):610-2.

49. Tseng, T.Y., Stoffs, T.L, Dahm, P.: Evidence-based urology in practice: publication bias. BJU Int (2010) 106(3):318-20.

50. Turpen, R.M., Fesperman, S.F., Smith, W.A., Vieweg, J., Dahm, P.: Reporting Quality and Information Consistency of Randomized, Controlled Trials Presented as Abstracts at the American Urological Association Annual Meetings. J Urol (2010) 184(1):249-53.

51. Karl, A., Akl, E.A., Moy, M.L., Dahm, P.: Evidence-based Urology Working Group: Evidence-based urology in practice: loss to follow-up. BJU Int (2010) 106(1):24-6.

52. Sur, R.L., Dahm, P.: Evidence-based urology in practice: Kaplan-Meier Analysis. BJU Int (2010) 105(10):1360-2.

53. Folsom, C., Fesperman, S.F., Tojuola, B., Sultan, S., Dahm, P.: Direct-to-consumer Advertising for Urological Pharmaceuticals: A Cross-sectional Analysis of Print Media. Urology (2010) 75(5):1029-33.

54. Turpen, R.M., Fesperman, S.F., Sultan, S., Borawski, K.M., Norris, R.D., Klink, J., Sur, R.L., Breau, R.H., Krupski, T.L., Dahm, P.: Levels of Evidence Ratings in the Urological Literature: An Assessment of Interobserver Agreement. BJU Int (2010) 105(5):602-6.

55. Canfield, S.E., Dahm, P.; Evidence-based Urology Working Group: Evidence-based urology in practice: incorporating patient values in evidence-based clinical decision-making. BJU Int (2010) 105(1):4-5.

56. Wang, S.S., Ou, Y.C., Cheng, C.L., Dahm, P.; Evidence-based Urology Working Group: Evidence-based urology in practice: when to believe a subgroup analysis? BJU Int (2010) 105(2):162-4.

57. Kang, D.C., Hardee, M.J., Fesperman, S.F., Stoffs, T.L., Dahm, P.: Low Quality of Evidence for Robot-Assisted Laparoscopic Prostatectomy: Results of a Systematic Review of the Published Literature. Eur Urol (2010) 57(6):930-7.

58. Dahm, P., Gilbert, S.M., Zlotecki, R.A., Guyatt, G.H.: Users’ Guide to the Urological Literature: How to Use an Article about Prognosis. J Urol (2010) 183(4):1303-8.

59. Imamura, M., Cook, J., MacLennan, S., N’Dow, J., Dahm, P.; Evidence-Based Urology Working Group: Evidence-based urology in practice: heterogeneity in a systematic review meta-analysis. BJU Int (2010) 105(6):770-3.

60. Sun, X., Briel, M., Busse, J.W., Akl, E.A., You, J.J., Mejza, F., Bala, M., Diaz-Granados, N., Bassler, D., Mertz, D., Srinathan, S.K., Vandvik, P.O., Malaga, G., Alshurafa, M., Dahm, P., Alonso-Coello, P., Heels-Ansdell, D.M., Bhatnagar, N., Johnston, B.C., Wang, L., Walter, S.D., Altman, D.G., Guyatt, G.H.: Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials. Trials (2009) 10:101. doi:10.1186/1745-6215-10-101

61. D'Alonzo, R.C., Gan, T.J., Moul, J.W., Albala, D.M., Polascik, T.J., Robertson, C.N., Sun, L., Dahm, P., Habib, A.S.: A Retrospective Comparison of Anesthetic Management of Robot- Assisted Laparoscopic Radical Prostatectomy Versus Radical Retropubic Prostatectomy. J Clin Anesth (2009) 21(5):322-8.

62. Dahm, P., Rosser, C.J., McKiernan, J.M.: Quality of care for testis cancer. Urol Oncol (2009) 27(4):448-53.

63. Singh, C., Dahm, P.: Relevance of levels of evidence to the urologist. Urology J (2009) 6(4):245-8.

64. Scales, Jr., C.D., Zarei, M., Dahm, P.; Evidence-Based Urology Working Group: Evidence- based urology in practice: likelihood ratios. BJU Int (2009) 104(7):892-4.

65. Hajebrahimi, S., Dahm, P., Buckingham, J.; Evidence-Based Urology Working Group: Evidence-based urology in practice: the Cochrane library. BJU Int (2009) 104(8):1048-9.

66. Mazel, J.W., Dahm, P.; Evidence-Based Urology Working Group: Evidence-based urology in practice: intention-to-treat analysis. BJU Int (2009) 104(5):582-3.

67. Breau, R.H., Fergusson, D., Dahm, P.; Evidence-Based Urology Working Group: Evidence- based urology in practice: number needed to treat. BJU Int (2009) 104(1):6-8.

68. Pop, G.H., Fesperman, S.F., Ball, D.A., Yeung, L.L., Vieweg, J., Dahm, P.: Duplicate Presentations on Prostate Cancer at American Urological Association and European Association of Urology Annual Meetings. J Urol (2009) 182(2):674-8; discussion 678-9.

69. Krupski, T.L., Schardt, C.M., Fesperman, S.F., Dahm, P.; Evidence-Based Urology Working Group: Evidence-based urology in practice: how to use PubMed effectively. BJU Int (2009) 103(9):1156-9.

70. Singh, J.C., Dahm P.: Evidence-based urology in practice: what are levels of evidence? BJU Int (2009) 103(7):860-1.

71. Dahm, P., Yeung, L., Schünemann, H.: Re: Gunnar Aus, Christopher Chapple, Tomas Hanus, et al. The European Association of Urology (EAU) Guidelines Methodology: A Critical Evaluation. Eur Urol (2009) 56(5):859-64.

72. Breau, R.H., Dahm, P., Fergusson, D.A., Hatala, R.: Users’ Guide to the Urological Literature: Understanding Results. J Urol (2009) 181(3):985-92.

73. Tseng, T.Y., Breau, R.H., Fesperman, S.F., Vieweg, J., Dahm, P.: Evaluating the Evidence: The Methodological and Reporting Quality of Comparative Observational Studies of Surgical Interventions in Urological Publications. BJU Int (2009) 103(8):1026-31.

74. Dahm, P., Yeung, L.L., Gallucci, M., Simone, G., Schunemann, H.J.: Users’ Guide to the Urological Literature: How to Use a Clinical Practice Guideline. J Urol (2009) 181(2):472-9.

75. Dahm, P., Poolman, R.W., Bhandari, M., Fesperman, S.F., Baum, J., Kosiak, B., Carrick, T., Preminger, G.M.: Perceptions and Competence in Evidence-Based Medicine: A Survey of the American Urological Association Membership. J Urol (2009) 181(2):767-77.

76. Kang, D., Hardee, M.J., Fesperman, S.F., Vieweg, J., Parekattil, S.J., Dahm, P.: Evaluating the Evidence: Quality of Reporting of Studies on Robotic-Assisted Laparoscopic Prostatectomy. J Urol (2008) 179(4 Supplement 1):494.

77. Bajammal, S., Bhandari, M., Dahm, P.: What Every Urologist Should Know about Surgical Trials Part II: What are the Results and Should I Apply Them to Patient Care? Indian J Urol (2008) 24(4):437-43.

78. Kusmartsev, S., Su, Z., Heiser, A., Dannull, J., Eruslanov, E., Kübler, H., Yancey, D., Dahm, P., Vieweg, J.: Reversal of Myeloid Cell-Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma. Clin Can Res (2008) 14(24):8270-8.

79. Dahm, P.: Evidence-Based Clinical Practice: An Introduction for Urologists. Urol Listy (2008) 4(6):70-7.

80. Bajammal, S., Dahm, P., Scarpero, H.M., Orovan, W., Bhandari, M.: Users’ Guide to the Urological Literature: How to Use an Article about Therapy. J Urol (2008) 180(5):1904-11.

81. Tseng, T.Y., Dahm, P., Poolman, R.W., Preminger, G.M., Canales, B.J., Montori, V.M.: Users’ Guide to the Urological Literature: How to Use a Systematic Literature Review and Meta-Analysis. J Urol (2008) 180(4):1249-56.

82. Scales, Jr., C.D., Norris, R.D., Preminger, G.M., Vieweg, J., Peterson, B.L., Dahm, P.: Evaluating the Evidence: Statistical Methods in Randomized Controlled Trials in the Urological Literature. J Urol (2008) 180(4):1463-7.

83. Bajammal, S., Bhandari, M., Dahm, P.: What Every Urologist Should Know about Surgical Trials Part I: Are the Results Valid? Indian J Urol (2008) 24(3):281-8.

84. Scales, C.D., Jr., Dahm, P., Sultan, S., Campbell-Scherer, D., Devereaux, P.J.: Users’ Guide to the Urological Literature: How to Use an Article about a Diagnostic Test. J Urol (2008) 180(2):469-76.

85. Dahm, P., Yeung, L.L., Chang, S.S., Cookson, M.S.: A Critical Review of Clinical Practice Guidelines for the Management of Patients with Clinically Localized Prostate Cancer. J Urol (2008) 180(2):451-9.

86. Kusmartsev, S., Eruslanov, E., Kübler, H., Tseng, T., Sakai, Y., Su, Z., Kaliberov, S., Heiser, A., Rosser, C., Dahm, P., Siemann, D., Vieweg, J.: Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma. J Immunol (2008) 181(1):346-53.

87. Scales, C.D., Jr., Voils, C.I., Fesperman, S.F., Sur, R.L., Kubler, H., Preminger, G.M., Dahm, P.: Barriers to the Practice of Evidence-Based Urology. J Urol (2008) 179(6):2345-9.

88. Scales, C.D., Jr., Dahm, P.: The Critical Use of Population-Based Medical Databases for Prostate Cancer Research. Curr Opin Urol (2008) 18(3):320-5.

89. Krupski, T.L., Dahm, P., Fesperman, S.F., Schardt, C.: User’s Guide to the Urological Literature: How to Search the Literature. J Urol (2008) 179(4):1264-70.

90. Fesperman, S.F., West, C.S., Bischoff, C.J., Algood, C.B., Vieweg, J., Dahm, P.: Study Characteristics of Abstracts Presented at the Annual Meetings of the Southeastern Section of the American Urological Association (1996-2005). J Urol (2008) 179(2):667-71.

91. Yeung, L.L., Vieweg, J., Khan, S.R., Newman, R.C., Dahm, P.: A Tribute to the Life and Accomplishments of Birdwell Finlayson. J Urol (2008) 179(3):842-6.

92. Fitzsimons, N.J., Sun, L.L., Dahm, P., Moul, J.W., Madden, J., Gan, T.J., Freedland, S.J.: A Single-Institution Comparison between Radical Perineal and Radical Retropubic Prostatectomy on Perioperative and Pathological Outcomes for Obese Men: An Analysis of the Duke Prostate Cancer Database. Urology (2007) 70(6):1146-51.

93. Borawski, K.M., Norris, R.D., Fesperman, S.F., Vieweg, J., Dahm, P.: Levels of Evidence in the Urology Literature. J Urol (2007) 178(4 pt 1):1429-33.

94. Dahm, P., Preminger, G.M.: A Users’ Guide to the Urological Literature: Introducing a Series of Evidence-Based Medicine Review Articles. J Urol (2007) 178(4):1149.

95. Moore, C.D., Erhard, M.J., Dahm, P.: Robot-assisted excision of seminal vesicle cysts associated with renal agenesis. J Endourology (2007) 21(7):776-9.

96. Scales, C.D., Jr., Preminger, G.M., Keitz, S.A., Dahm, P.: Evidence-Based Clinical Practice: A Primer for Urologists. J Urol (2007) 178(3 pt 1):775-82.

97. Kubler, H.R., Tseng, T.Y., Sun, L., Vieweg, J., Harris, M.J., Dahm, P.: Impact of Nerve Sparing Technique on Patient Self-Assessed Outcomes after Radical Perineal Prostatectomy. J Urol. (2007) 178(2):448-92.

98. Dahm, P., Preminger, G.M.: Introducing Levels of Evidence to Publications in Urology. BJU Int (2007) 100(2):246-7.

99. Dahm, P., Kunz, R., Schunemann, H.: Evidence-Based Clinical Practice Guidelines for Prostate Cancer: The Need for a Unified Approach. Curr Opin Urol (2007) 17(3):200-7.

100. Tseng, T., Kübler, H., Cancel, Q., Sun, L., Robertson, C., Polascik, T., Moul, J., Vieweg, J., Albala, D.M., Dahm, P.: The Role of Early Adopter Bias for New Technologies in Robot Assisted Laparoscopic Prostatectomy. J Urol (2007) 177(4):1318-23.

101. Scales, C.D., Jr., Norris, R.D., Keitz, S.A., Peterson, B.L., Preminger, G.M., Vieweg, J., Dahm, P.: A Critical Assessment of the Quality of Reporting of Randomized Controlled Trials in the Urology Literature. J Urol (2007) 177(3):1090-4.

102. Smith, W.A, Cancel, Q.A., Tseng, T.Y., Sultan, S., Vieweg, J., Dahm, P.: Factors Associated with the Full Publication of Studies Presented in Abstract Form at the Annual Meeting of the American Urological Association. J Urol (2007) 177(3):1084-9.

103. Scales, C.D., Jr., Curtis, L.H., Norris, R.D., Schulman, K.A., Dahm P., Moul J.W.: Relationship between body mass index and prostate cancer screening in the United States. J Urol (2007) 177(2):493-8.

104. Sun, L., Moul, J.W., Hotaling, J.M., Rampersaud, E., Dahm, P., Robertson, C., Fitzsimons, N., Albala, D., Polascik, T.J. Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years. BJU Int (2007) 99(4):753-7.

105. Vieweg, J., Su, Z., Dahm, P., Kusmartsev, S.: Reversal of Tumor-Mediated Immunosuppression: A Review. Clinical Cancer Res (2007) 13(2Pt2):727s-732s.

106. Moul, J.W., Sun, L., Hotaling, J.M., Fitzsimons, N.J., Polascik, T.J., Robertson, C.N., Dahm, P., Anscher, M.S., Mouraviev, V., Pappas, P.A., Albala, D.M.: Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol (2007) 177(2):499-503.

107. Scales, Jr., C.D., Peterson, B.L., Dahm, P.: Interpreting Statistics in the Urologic Literature. J Urol (2006) 176(5):1938-45.

108. Tseng, T.Y., Kübler, H.R., Cancel, Q.V., Sun, L., Springhart, W.P., Murphy, B.C., Albala, D.M., Dahm, P.: Prospective Health-Related Quality of Life Assessment in an Initial Cohort of Robotic Radical Prostatectomy Patients. Urology (2006) 68(5):1061-66.

109. Anscher, M.S., Clough, R., Robertson, C.N., Prosnitz, L.R., Dahm, P., Walther, P., Donatucci, C.F., Albala, D.M., Febbo, P., George, D.J., Sun, L., Moul, J.W.: Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate. Prostate Cancer Prostatic Dis (2006) 9(3):254-60.

110. Sur, R.L., Scales, Jr., C.D., Preminger, G.M., Dahm, P.: Evidence-Based Medicine: A Survey of Members of the American Urological Association. J Urol (2006) 176(3):1127-34.

111. Yang, B.K., Gan, T.J., Salmen, C.R., Cancel, Q.V., Vieweg, J., Dahm, P.: Radical perineal prostatectomy for treatment of localized prostate cancer in obese and nonobese patients: a matched control study. Urology (2006) 67(5):990-5.

112. Dahm, P., Sur, R., Scales, C., Preminger, G.M.: Evidence-Based Medicine in Urology. AUA Update Series, 2006, Volume 25, Lesson 25.

113. Dahm, P.: Evidence-Based Medicine in Prostate Cancer: Where Do We Stand in 2006? Curr Opin Urol (2006) 16(3):162-7.

114. Dannull, J., Su, Z., Rizzieri, D., Yang, B.K., Coleman, D., Yancey, D., Zhang, A., Dahm, P., Chao, N., Gilboa, E., Vieweg, J.: Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest (2005) 115(12):3623-33.

115. Scales, Jr., C.D., Norris, R.D., Peterson, B.L., Preminger, G.M., Dahm, P.: Clinical research and statistical methods in the urology literature. J Urol (2005) 174(4 Pt 1):1374-9.

116. Wiygul, J.B., Harris, M.J., Dahm, P.: Early patient self-assessed outcomes of nerve-sparing radical perineal prostatectomy. Urology (2005) 66(3):582-6.

117. Dahm, P., Yang, B.K., Salmen, C.R., Moul, J.W., Gan, T.J.: Radical perineal prostatectomy for the treatment of localized prostate cancer in morbidly obese patients. J Urol (2005) 171(1):131-4.

118. Su, Z., Dannull, J., Yang, B., Dahm, P., Coleman, D., Yancey, D., Sichi, S., Niedzwiecki, D., Nair, S., Boczkowski, D., Gilboa, E., Vieweg, J.: Telomerase mRNA transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T-cell responses in patients with metastatic prostate cancer. J Immunol (2005) 174(6):3798-3807.

119. Carleton, J., van der Riet, P., Dahm, P.: Metastatic prostate cancer presenting as an asymptomatic neck mass. Prostate Cancer Prostatic Dis (2005) 8(3):293-5.

120. Yang, B.K., Crisci, A., Young, M.D., Silverstein, A.D., Peterson, B.L., Dahm, P.: Cross- sectional survey of long-term quality of life after radical perineal prostatectomy. Urology (2005) 65(1):120-5.

121. Yang, B.K., Young, M.D., Calingaert, B., Albala, D.M., Vieweg, J., Murphy, B.C., Dahm, P.: Prospective and Longitudinal Patient Self-Assessment of Health-Related Quality of Life Following Radical Perineal Prostatectomy. J Urol (2004) 172(1):264-8.

122. Poulakis, V., Dahm, P., Witzsch, U., Sutton, A., Becht, E.: Transurethral Electrovaporization versus Transurethral Resection for Symptomatic Prostatic Obstruction: A Meta-analysis. BJU Int (2004) 94(1):89-95.

123. Ekeruo, W.O., Tan, Y.H., Young, M.D., Dahm, P., Maloney, M.E., Mathias, B.J., Albala, D.M., Preminger, G.M.: Metabolic Risk Factors and the Impact of Medical Therapy on the Management of Nephrolithiasis in Obese Patients. J Urol (2004) 172(1):159-63.

124. Dahm, P., Gschwend, J.: Primary Non-Urothelial Neoplasms of the Urinary Bladder. AUA Update Series (2004) Volume 23, Lesson 6.

125. Dahm, P., Vieweg, J.: Evolving Immunotherapeutic Strategies for the Treatment of Prostate and Renal Carcinomas. AUA Update Series (2004) Volume 23, Lesson 4.

126. Silverstein, A.V., Weizer, A.Z., Dowell, J.M., Auge, B.K., Paulson, D.F., Dahm, P.: Cost Comparison of Radical Retropubic and Radical Perineal Prostatectomy: Single Institution Experience. Urology (2004) 63(4):746-50.

127. Crisci, A., Young, M.D., Murphy, B.C., Paulson, D.F., Dahm, P.: Ureteral Reimplantation for Inadvertent Ureteral Injury During Radical Perineal Prostatectomy. Urology (2003) 62(5):941.

128. Dahm, F., Dahm, P., Dahm, J.: Vasektomie Heute: Eine Bestandserhebung Nach 1275 Vasektomien in 10 Jahren. Urologe A. (2003) 42(7):933-9.

129. Dahm, P. Gschwend, J.: Malignant Non-Urothelial Neoplasms of the Urinary Bladder: A Review. Eur Urol (2003) 44(6):672-81.

130. Young, M.D., Silverstein, A.D., Weizer, A.Z., Crisci, A., Albala, D.M., Vieweg, J., Paulson, D.F., Dahm, P.: Urinary Continence and Quality of Life in the First Year After Radical Perineal Prostatectomy. J Urol (2003) 170:2374-8.

131. Weizer, A., Silverstein, A., Young, M., Vieweg, J., Paulson, D., Dahm, P.: A Prospective Evaluation of Pain Medication Requirements and Recovery After Radical Perineal Prostatectomy. Urology (2003) 62(4):693-7.

132. Dahm, P., Silverstein, A., Weizer, A., Vieweg, J., Paulson, D.: When to Diagnose and How to Treat Prostate Cancer in the “Not Too Fit” Elderly. Critical Reviews in Oncology Hematology (2003) 48(2):123-31.

133. Dahm, P., Silverstein A.D., Weizer A.Z., Young, M.D., Vieweg, J., Albala D.M., Paulson D.F.: A Longitudinal Assessment of Bowel Related Symptoms and Fecal Incontinence Following Radical Perineal Prostatectomy. J Urol (2003) 169(6):2220-4.

134. Poulakis, V., Dahm, P., Witzsch, U., De Vries, R., Remplik, J., Becht, E.: Prediction of Lower Pole Stone Clearance After Shock Wave Lithotripsy Using an Artificial Neural Network. J Urol (2003) 169(4):1250-6.

135. Dahm, P., Paulson, D.F., Albala, D.M.: Management of retained retractor during radical perineal prostatectomy. J Urol (2003) 169(3):1085.

136. Weizer, A., Auge, B.K., Silverstein, A.D., Delvecchio, F.C., Brizuela, R.M., Dahm, P., Pietrow, P.K., Lewis, B.R., Albala, D.M., Preminger, G.M.: Routine postoperative imaging is important after ureteroscopic stone manipulation. J Urol (2002) 168(1):46-50.

137. Su, Z., Vieweg, J., Weizer, A.Z., Dahm, P., Yancey, D., Turaga, V., Higgins, J., Boczkowski, D., Gilboa, E., Dannull, J.: Enhanced Induction of Telomerase-specific CD4(+) T Cells Using

Dendritic Cells Transfected with RNA Encoding a Chimeric Gene Product. Cancer Res (2002) 62(17):5041-8.

138. Heiser, A., Coleman, D., Dannull, J., Yancey, D., Maurice, M.A., Lallas, C.D., Dahm, P., Niedzwiecki, D., Gilboa, E., Vieweg, J.: Autologous dendritic cells transfected with prostate- specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest (2002) 109(3):409-17.

139. Gschwend, J.E., Dahm, P., Fair, W.R.: Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol (2002) 41(4):440-8.

140. Dahm, P., Rao, D.S., Donatucci, C.F.: Antiandrogens in the treatment of priapism. Urology (2002) 59(1):138.

141. Heiser, A., Maurice, M., Yancey, D., Wu, N.Z., Dahm, P., Pruitt, S.K., Boczkowski, D., Nair, S.K., Gilboa, E., Vieweg, J.: Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected With Amplified Tumor RNA. J Immunol (2001) 166(5):2953-60.

142. Heiser, A., Maurice, M.A., Yancey, D.R., Coleman, D.M., Dahm, P., Vieweg, J.: Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Cancer Res (2001) 61(8):3388-93.

143. Auge, B.K., Dahm, P., Wu, N.Z., Preminger, G.M.: Ureteroscopic management of lower-pole renal calculi: technique of calculus displacement. J Endourol (2001) 15(8):835-8.

144. Dahm, P., Newhall, J.E., Nimjee, S.M., Byrne, R.R., Yowell, C.W., Price, D.T.: Indications for Admission to the Surgical Intensive Care Unit (SICU) Following Radical Cystectomy and Urinary Diversion. J Urol (2001) 166(1):189-93.

145. Young M.D., Dahm, P., Robertson, C.N.: Prostatic sarcoma with rapid tumor progression following nerve-sparing radical cystoprostatectomy. J Urol (2001) 166(3):994.

146. Gregori, A., Vieweg, J., Dahm, P., Paulson, D.F.: Comparison of ultrasound-guided biopsies and prostatectomy specimens: Predictive accuracy of Gleason score and tumor site. Urol Int (2001) 66(2):66-71.

147. Dahm, P., Paulson, D.F.: The role of radical cystectomy for superficial bladder cancer.
Urologia Integrada y de Investigacion (2001) 6(2):134-8.

148. Heiser, A., Dahm, P., Yancey, D., Maurice, M., Boczkowski, D., Nair, S.K., Gilboa, E., Vieweg, J.: Human Dendritic Cells Transfected With RNA Encoding Prostate Specific Antigen (PSA) Stimulate Prostate Specific CTL Responses In Vitro. J Immunol (2000) 164(10):5508-14.

149. Dahm, P., Vieweg J., Newhall P.M., Robertson J.E., Paulson, D.F.: Outcome Profiles of Loco-Regional Disease after Radical Prostatectomy and Radiotherapy. World J Urol (2000) 18(3):173-8.

150. Dahm, P., Tuttle-Newhall, J.E., Yowell, C.W., Byrne, R.R., Price, D.T.: Indications for Surgical Intensive Care Unit Admission of Postoperative Urologic Patients. Urology (2000) 55(3):334-8.

151. Dahm, P., Roland, F., Vaslef, S.N., Moon, R.E., Price, D.T., Georgiade, G.S., Vieweg, J.: Outcome Analysis in Patients with Primary Necrotizing Fasciitis of the Male Genitalia. Urology (2000) 56(1):31-5.

152. Dahm, P., Vieweg, J., Iselin, C.E., Gregori, A., Robertson, J.E., Paulson, D.F.: Outcome in Radical Perineal Prostatectomy. Akt Urol (1999) 5:347-51.

153. Dahm, P., Szukala, S., Byrne, R.R., Price, D.T.: Giant Hepatoid Yolk Sac Tumor in a Black Man. J Urol (1999) 162:801-2.

154. Dahm, P., King, L.R.: Experience with Transurethral Incision of Ureteroceles. Urol Int (1998) 61(3):157-61.

155. Dahm, P., Dahm, J.: Die Ambulant Durchgefuhrte Minimal-Invasive Vasektomie. Urologe B (1997) 37:496-9.

156. Dahm, P., Manseck, A., Flössel, C., Saeger, H.H., Wirth, M.: Malignant Neurofibroma of the Urinary Bladder. Eur Urol (1995) 27(3):261-3.